Paris Stock Exchange plunges under biotech and Atos pressure
Several French biotech stocks plummet on June 24 on the Paris Stock Exchange.
Published 3sem1 sourceMajorupdated 4j
Lire en français
≈ 19s
The fact
Abivax drops 10% without volume, Nanobiotix and Genfit follow, as the CAC 40 declines.
Investors flee the sector after disappointing clinical results and concerns over Atos.
Click the link to read an article on the topic: